Showing 161 - 180 results of 2,975 for search '(( significantly ((weaker decrease) OR (teer decrease)) ) OR ( significant decrease release ))', query time: 0.88s Refine Results
  1. 161
  2. 162
  3. 163

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168

    Effect of previous administration of extended-release buprenorphine (1 mg/kg SC) or saline in rats using a warm-water tail flick assay to assess acute thermal nociception. by Christina M. Larson (18196213)

    Published 2024
    “…A) Efficacy in response to standard buprenorphine at 1 mg/kg and 3 mg/kg was significantly decreased in rats previously exposed to extended-release buprenorphine (Bupe ER) vs. those exposed to saline. …”
  9. 169
  10. 170
  11. 171

    SASP release from ASM changes with age. by Sarah A. Wicher (11204226)

    Published 2021
    “…IL-6 release decreased in middle aged ASM cells (C). Data shown as mean ± SEM from <i>n</i> = 7–9 patients. …”
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176

    Fig 2 - by Sigrid Nilsson (12647302)

    Published 2022
    Subjects:
  17. 177
  18. 178
  19. 179
  20. 180

    S1 Data - by Sigrid Nilsson (12647302)

    Published 2022
    Subjects: